Pasar al contenido principal

MAP3K8 Y HORMONAS TIROIDEAS NUEVAS DIANAS EN LA MALARIA EXPERIMENTAL

SAF2017-83289-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Abnormal dendritic cell-poiesis in patients with lower-risk myelodysplastic syndromes

  • Sánchez, Ángela
  • Anguita, Eduardo
  • Chaparro, Alberto
  • Etcheverry, Roldán
  • José, Juan
  • López-García, Alberto
  • Ramos-Acosta, Carlos
  • Oancea, Raluca
  • Rodriguez-Muñoz, Diego
  • Alemany, Susana
© 2020 the Author(s)., Myelodysplastic syndromes (MDS) are clonal hematopoietic stem/progenitor cell disorders associated with ineffective hematopoiesis and peripheral blood cytopenia(s). Mounting evidence suggests that immune system regulation plays an important role in MDS pathogenesis and progression.1 The Revised International Prognostic Scoring System (IPSS-R) divided MDS patients in four risk groups,2 in which, for simplicity's sake, very low, low, and intermediate risk groups can be united into one lower-risk MDS group, as higher-risk MDSs are closer to acute myeloid leukemia., This work was supported by SAF2014-52009-R (SA) and SAF2017-83289-R (SA) from the Spanish Ministry of Economy and Competitiveness and by the European Regional Development Funds (FEDER), B2017/BMD-3724 (SA) from the Comunidad de Madrid and Hay Esperanza Foundation (EA).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stress erythropoiesis in atherogenic mice

  • Sánchez, Ángela
  • Orizaola, Marta C.
  • Rodriguez-Muñoz, Diego
  • Aranda, Ana
  • Castrillo, Antonio
  • Alemany, Susana
© The Author(s) 2020., Bone marrow erythropoiesis is mainly homeostatic and a demand of oxygen in tissues activates stress erythropoiesis in the spleen. Here, we show an increase in the number of circulating erythrocytes in apolipoprotein E−/− mice fed a Western high-fat diet, with similar number of circulating leukocytes and CD41+ events (platelets). Atherogenic conditions increase spleen erythropoiesis with no variations of this cell lineage in the bone marrow. Spleens from atherogenic mice show augmented number of late-stage erythroblasts and biased differentiation of progenitor cells towards the erythroid cell lineage, with an increase of CD71+CD41CD34−CD117+Sca1−Lin− cells (erythroid-primed megakaryocyte-erythroid progenitors), which is consistent with the way in which atherogenesis modifies the expression of pro-erythroid and pro-megakaryocytic genes in megakaryocyte-erythroid progenitors. These data explain the transiently improved response to an acute severe hemolytic anemia insult found in atherogenic mice in comparison to control mice, as well as the higher burst-forming unit-erythroid and colony forming unit-erythroid capacity of splenocytes from atherogenic mice. In conclusion, our work demonstrates that, along with the well stablished enhancement of monocytosis during atherogenesis, stress erythropoiesis in apolipoprotein E−/− mice fed a Western high fat diet results in increased numbers of circulating red blood cells., Tis work was supported by the following grants: SAF2017-83289-R (AA, SA) from the Spanish Ministry of the Economy and Competitiveness and the European Regional Development Funds (FEDER); and B2017/BMD3724 (AA, SA) from the Comunidad de Madrid.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development

  • Font-Díaz, Joan
  • Jiménez-Panizo, Alba
  • Caelles, Carme
  • Vivanco, María d. M.
  • Pérez, Paloma
  • Aranda, Ana
  • Estébanez-Perpiñá, Eva
  • Castrillo, Antonio
  • Ricote, M. Mercedes
  • Valledor, Annabel F.
Versión de autor del artículo, 93 páginas, 3 figuras 1 tabla, Nuclear receptors (NRs) are a superfamily of ligand-activated transcription factors that act as biological sensors and use a combination of mechanisms to modulate positively and negatively gene expression in a spatial and temporal manner. The highly orchestrated biological actions of several NRs influence the proliferation, differentiation, and apoptosis of many different cell types. Synthetic ligands for several NRs have been the focus of extensive drug discovery efforts for cancer intervention. This review summarizes the roles in tumour growth and metastasis of several relevant NR family members, namely androgen receptor (AR), estrogen receptor (ER), glucocorticoid receptor (GR), thyroid hormone receptor (TR), retinoic acid receptors (RARs), retinoid X receptors (RXRs), peroxisome proliferator-activated receptors (PPARs), and liver X receptors (LXRs). These studies are key to develop improved therapeutic agents based on novel modes of action with reduced side effects and overcoming resistance., This work was supported by grants from the Spanish Ministry of Economy and Competitivity (MINECO) to AFV and CC (SAF2017-89510- R), to AA (SAF2017-83289-R), to MV (SAF2017-84934-R), to PP (SAF2017-88046-R), to EE (BFU2017-86906-R), and to the NuRCaMeIn network (SAF2017-90604REDT); grants from the Spanish Ministry of Science, Innovation and Universities (MCNU) and Fondo Europeo de Desarrollo Regional (FEDER) to MR (RTI2018-095928-B100) and AC (PID2019-104284RB-I00/AEI/10.13039/501100011033); a grant from Instituto de Salud Carlos III to AA (CIBERONC CB/16/00228); grants from the Autonomous Community of Madrid to AA (B2017/BMD-3724) and MR (MOIR-B2017/BMD-3684); grants from Fundació La Marato ´ de TV3 to CC (201605-30), AFV (201605-31) and MR (201605-32); a grant from the Government of the Autonomous Community of Basque Country, Department of Industry, Tourism and Trade to MV (Elkartek, KK-2018/ 00054); and a grant from La Caixa to EEP (CaixaImpulse-CI-0018). JFD received a fellowship from the Spanish Ministry of Science, Innovation and Universities (FPI, PRE2018-085579). The CNIC is supported by the MCNU and the Pro CNIC Foundation and is a Severo Ochoa Centre of Excellence (SEV-2015-0505). CIC bioGUNE is a Severo Ochoa Centre of Excellence (SEV-2016-0644), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MicroRNAs and thyroid hormone action

  • Aranda, Ana
MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally repress gene expression by binding generally to the 3′-untranslated regions of their target mRNAs. miRNAs regulate a large fraction of the genome, playing a key role in most physiological and pathological processes. The thyroid hormones (T4 and T3) are major regulators of development, metabolism and cell growth. The thyroid hormones (THs) are synthetized in the thyroid gland and enter the cells through transporter proteins. In the cells, T4 and T3 are metabolized by deiodinase enzymes and bind to nuclear receptors (TRs), which have a higher affinity by T3. TRs act as hormone dependent transcription factors by binding to thyroid hormone response elements (TREs) in the target genes and recruiting transcriptional coregulators. There is increasing evidence that a variety of miRNAs target deiodinases and the receptor, thus regulating TH signaling is different tissues. In turn, the THs have been shown to modulate the expression of specific miRNAs and their mRNA targets in different cell types and organs. In many cases, the existence of TREs in the regulatory regions of these miRNAs has been identified, and the hormone bound receptors transcriptionally regulate expression of these molecules. Changes in the levels of miRNAs have been demonstrated to mediate some of the important actions of the THs in processes such as muscle and heart function, lipid liver metabolism or skin physiology. In addition, miRNA regulation is involved in the effects of TRs on cell proliferation and cancer., This laboratory is supported by grants SAF 2017-83289-R and SAF 2017-90604-REDT (Ministerio de Ciencias, Innovación y Universidades), B2017/BMD-3724 (Comunidad de Madrid) and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer

  • Martínez-Iglesias, Olaia
  • Ruiz-Llorente, Lidia
  • Contreras-Jurado, Constanza
  • Aranda, Ana
The thyroid hormone receptors, TRα and TRβ, are ligand-dependent transcription factors that regulate gene expression by recruitment of coactivators and corepressors. These receptors play an important role in normal and malignant cell proliferation. TRs can antagonize ras-dependent proliferation, transformation, and tumorigenesis. Furthermore, expression of TRβ1 in cancer cells retards tumor growth and inhibits invasion, extravasation, lymphangiogenesis, and metastasis formation in euthyroid nude mice. The corepressor NCoR is required for these tumor-suppressor actions of the receptor. When cells are inoculated into hypothyroid hosts, tumor growth is retarded, but metastatic growth is enhanced. Increased malignancy of skin tumors is found in mice lacking TRs, further demonstrating the role of these receptors as inhibitors of tumor progression. TRs have a dual effect on proliferation because they are required for proliferation of normal hepatocytes or keratinocytes and activation and mobilization of skin stem cells while acting as inhibitors of tumor progression., The laboratory of Ana Aranda is supported by Grants SAF2017-83289-R and SAF2017-90604-REDT (Ministerio de Ciencias, Innovación y Universidades) and B2017/BMD-3724 (Comunidad de Madrid)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hypothyroidism confers tolerance to cerebral malaria

  • Rodriguez-Muñoz, Diego
  • Sánchez, Ángela
  • Pérez-Benavente, Susana
  • Contreras-Jurado, Constanza
  • Montero-Pedrazuela, Ana
  • Toledo-Castillo, Marta
  • Gutiérrez-Hernández, María
  • Rodrigues-Díez, Raquel
  • Folgueira, Cintia
  • Briones, Ana M.
  • Sabio, Guadalupe
  • Monedero-Cobeta, Ignacio
  • Chaves-Coira, Irene
  • Castejón, David
  • Fernández-Valle, Encarnación
  • Regadera, Javier
  • Bautista, José M.
  • Aranda, Ana
  • Alemany, Susana
The modulation of the host’s metabolism to protect tissue from damage induces tolerance to infections increasing survival. Here, we examined the role of the thyroid hormones, key metabolic regulators, in the outcome of malaria. Hypothyroidism confers protection to experimental cerebral malaria by a disease tolerance mechanism. Hypothyroid mice display increased survival after infection with Plasmodium berghei ANKA, diminishing intracranial pressure and brain damage, without altering pathogen burden, blood-brain barrier disruption, or immune cell infiltration. This protection is reversed by treatment with a Sirtuin 1 inhibitor, while treatment of euthyroid mice with a Sirtuin 1 activator induces tolerance and reduces intracranial pressure and lethality. This indicates that thyroid hormones and Sirtuin 1 are previously unknown targets for cerebral malaria treatment, a major killer of children in endemic malaria areas., This work was funded by grants SAF2017-83289-R to S.A. and A.A., SAF2017-90604REDT to A.A. supported by the The European Regional Development Fund (FEDER) and BIO2016-77430-R to J.M.B. from the Ministerio de Economía y Competitividad; B2017/BMD-3724 to S.A. and A.A. from the Comunidad de Madrid; and CIBERONC CB/16/00228 to A.A. from the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of metabolic and transcriptional responses by the thyroid hormone in cellular models of murine macrophages

  • López-Mateo, Irene
  • Rodriguez-Muñoz, Diego
  • Rosa, Juan V. de la
  • Castrillo, Antonio
  • Alemany, Susana
  • Aranda, Ana
Oncogene-immortalized bone marrow-derived macrophages are considered to be a good model for the study of immune cell functions, but the factors required for their survival and proliferation are still unknown. Although the effect of the thyroid hormones on global metabolic and transcriptional responses in macrophages has not yet been examined, there is increasing evidence that they could modulate macrophage functions. We show here that the thyroid hormone T3 is an absolute requirement for the growth of immortal macrophages. The hormone regulates the activity of the main signaling pathways required for proliferation and anabolic processes, including the phosphorylation of ERK and p38 MAPKs, AKT, ribosomal S6 protein, AMPK and Sirtuin-1. T3 also alters the levels of metabolites controlling transcriptional and post-transcriptional actions in macrophages, and causes widespread transcriptomic changes, up-regulating genes needed for protein synthesis and cell proliferation, while down-regulating genes involved in immune responses and endocytosis, among others. This is not observed in primary bone marrow-derived macrophages, where only p38 and AMPK activation is regulated by T3 and in which the metabolic and transcriptomic effects of the hormone are much weaker. However, the response to IFN-γ is reduced by T3 similarly in immortalized macrophages and in the primary cells, confirming previous results showing that the thyroid hormones can antagonize JAK/STAT-mediated signaling. These results provide new perspectives on the relevant pathways involved in proliferation and survival of macrophage cell culture models and on the crosstalk between the thyroid hormones and the immune system., This work has been funded by grants SAF2017-83289-R and PID2020-116146RB-I00 to SA and AA, PID2019-104284RBI00/AEI/10.13039/501100011033 to AC and SAF2017-90604REDT to AA and AC from Ministerio de Ciencia Innovación y Universidades; by grant B2017/BMD-3724 to SA and AA from the Comunidad de Madrid; and by CIBERONC CB/16/00228 to AA from the Instituto de Salud Carlos III. The cost of this publication has been paid in part by FEDER Funds.